ConvaTec Group PLC (LON:CTEC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of ConvaTec Group PLC (LON:CTEC) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is GBX 306.

Several equities analysts have recently issued reports on CTEC shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 315 price objective on shares of ConvaTec Group in a report on Wednesday, August 5th. Peel Hunt reaffirmed an “add” rating and set a GBX 270 target price on shares of ConvaTec Group in a report on Tuesday, August 4th. Royal Bank Of Canada reiterated an “outperform” rating and set a GBX 315 price target on shares of ConvaTec Group in a research report on Monday, August 3rd. Citigroup decreased their price target on ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a report on Monday, May 18th. Finally, UBS Group restated a “buy” rating and issued a GBX 375 price objective on shares of ConvaTec Group in a research report on Monday, May 18th.

Insider Transactions at ConvaTec Group

In other news, insider Tobias Hestler acquired 50,000 shares of the business’s stock in a transaction on Thursday, August 6th. The stock was bought at an average price of GBX 226 per share, with a total value of £113,000. Company insiders own 0.98% of the company’s stock.

ConvaTec Group Price Performance

LON:CTEC opened at GBX 227.40 on Thursday. ConvaTec Group has a one year low of GBX 193 and a one year high of GBX 259.30. The company has a debt-to-equity ratio of 121.83, a quick ratio of 0.96 and a current ratio of 1.93. The firm has a market cap of £4.42 billion, a price-to-earnings ratio of 36.68, a PEG ratio of 0.93 and a beta of 0.77. The firm’s fifty day moving average is GBX 224 and its two-hundred day moving average is GBX 221.19.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.